KCP
PFE icon

Kera Capital Partners’s Pfizer PFE Stock Holding History

Kera Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$1.2K – 582
2025
Q3 		$1.2K Hold
10,000
– – ﹤0.01% 423
2025
Q2 		$800 Hold
10,000
– – ﹤0.01% 351
2025
Q1 		$2.2K Buy
+10,000
New +$262K ﹤0.01% 187

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Kera Capital Partners's PFE Position: Q1 2026 in Review

Kera Capital Partners increased its Pfizer (PFE) stake by 0.62% in Q1 2026, buying an estimated $1.94K and bringing the position to 11,823 shares worth $332K. The position accounts for 0.04% of the portfolio, ranked #377.

Kera Capital Partners first reported a position in PFE in Q3 2025 and has held it in 3 quarters since. The position peaked at $420K in Q3 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Kera Capital Partners held 11,823 shares of Pfizer worth $332K as of Q1 2026.
  • Kera Capital Partners bought 73 Pfizer shares in Q1 2026, an estimated $1.94K.
  • Pfizer made up 0.04% of Kera Capital Partners's portfolio in Q1 2026, its #377 holding.
  • Kera Capital Partners first reported a position in Pfizer in Q3 2025 and has held it in 3 quarters since.
  • Kera Capital Partners's Pfizer position peaked at $420K in Q3 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Kera Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.